Literature DB >> 33402208

A flexible short protocol in women with poor ovarian response over 40 years old.

Xinyue Zhang1, Ting Feng1, Jihong Yang1, Yingying Hao1, Suying Li1, Yan Zhang1, Yun Qian2.   

Abstract

BACKGROUND: Ovarian responsiveness to controlled ovarian stimulation is essential for a successful clinical outcome in assisted reproductive technology (ART) cycles. We aimed to find a suitable new ovulation stimulation protocol for poor ovarian response (POR) patients over 40 years old.
METHODS: A retrospective analysis of 488 ART cycles was evaluated from January 2015 to June 2019. Comparisons were made between the flexible short protocol (FSP), routine short protocol and mild stimulation protocol.
RESULTS: Compared with the routine short protocol, the FSP delayed the gonadotropin start time and reduced the total gonadotropin dose per stimulation cycle. At the same time, compared with the mild stimulation protocol, the FSP improved oocyte quality and embryo quality and improved embryo implantation potential after transfer. Furthermore, the use of the FSP reduced the probability of premature ovulation, as it inhibited the premature luteinizing hormone (LH) surge to a certain extent.
CONCLUSIONS: The FSP yielded better outcomes than other protocols for patients with POR over 40 years old in our study. However, further prospective studies are needed to provide more substantial evidence and to determine whether the FSP can be successful for both patients over 40 years group and younger POR patients.

Entities:  

Keywords:  Assisted reproductive technology; flexible; ovarian stimulation protocol; poor ovarian response

Year:  2021        PMID: 33402208      PMCID: PMC7786950          DOI: 10.1186/s13048-020-00761-1

Source DB:  PubMed          Journal:  J Ovarian Res        ISSN: 1757-2215            Impact factor:   4.234


  23 in total

Review 1.  Follicle-Stimulating Hormone: A Review of Form and Function in the Treatment of Infertility.

Authors:  Johan Smitz; Claudio Wolfenson; Scott Chappel; Jane Ruman
Journal:  Reprod Sci       Date:  2015-10-06       Impact factor: 3.060

2.  A novel "delayed start" protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders.

Authors:  Hakan Cakmak; Nam D Tran; A Musa Zamah; Marcelle I Cedars; Mitchell P Rosen
Journal:  Fertil Steril       Date:  2014-03-14       Impact factor: 7.329

Review 3.  Novel approaches for diagnosis and management of low prognosis patients in assisted reproductive technology: the POSEIDON concept.

Authors:  Alessandro Conforti; Sandro C Esteves; Silvia Picarelli; Giuseppe Iorio; Erika Rania; Fulvio Zullo; Giuseppe De Placido; Carlo Alviggi
Journal:  Panminerva Med       Date:  2018-07-18       Impact factor: 5.197

Review 4.  What is new in the management of poor ovarian response in IVF?

Authors:  Alberto Vaiarelli; Danilo Cimadomo; Nicolò Ubaldi; Laura Rienzi; Filippo Maria Ubaldi
Journal:  Curr Opin Obstet Gynecol       Date:  2018-06       Impact factor: 1.927

5.  A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial.

Authors:  M A Youssef; M van Wely; H Al-Inany; T Madani; N Jahangiri; S Khodabakhshi; M Alhalabi; M Akhondi; S Ansaripour; R Tokhmechy; L Zarandi; A Rizk; M El-Mohamedy; E Shaeer; M Khattab; M H Mochtar; F van der Veen
Journal:  Hum Reprod       Date:  2016-11-11       Impact factor: 6.918

6.  ART in Europe, 2014: results generated from European registries by ESHRE: The European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE).

Authors:  Ch De Geyter; C Calhaz-Jorge; M S Kupka; C Wyns; E Mocanu; T Motrenko; G Scaravelli; J Smeenk; S Vidakovic; V Goossens
Journal:  Hum Reprod       Date:  2018-09-01       Impact factor: 6.918

Review 7.  Gonadotropin Surge-Attenuating Factor: A Nonsteroidal Ovarian Hormone Controlling GnRH-Induced LH Secretion in the Normal Menstrual Cycle.

Authors:  Ioannis E Messinis; Christina I Messini; George Anifandis; Antonios Garas; Alexandros Daponte
Journal:  Vitam Horm       Date:  2018-02-09       Impact factor: 3.421

8.  Low anti-Müllerian hormone level is not a risk factor for early pregnancy loss in IVF/ICSI treatment.

Authors:  P Peuranpää; H Hautamäki; M Halttunen-Nieminen; C Hydén-Granskog; A Tiitinen
Journal:  Hum Reprod       Date:  2020-03-27       Impact factor: 6.918

9.  Cumulative Live Birth Rates Following Stimulation With Corifollitropin Alfa Compared With hp-hMG in a GnRH Antagonist Protocol in Poor Ovarian Responders.

Authors:  Joaquín Errázuriz; Alessia Romito; Panagiotis Drakopoulos; Billie Frederix; Analissa Racca; Neelke De Munck; Herman Tournaye; Michel De Vos; Christophe Blockeel
Journal:  Front Endocrinol (Lausanne)       Date:  2019-03-22       Impact factor: 5.555

10.  Hallmarks of Human Small Antral Follicle Development: Implications for Regulation of Ovarian Steroidogenesis and Selection of the Dominant Follicle.

Authors:  Stine G Kristensen; Linn S Mamsen; Janni V Jeppesen; Jane Alrø Bøtkjær; Susanne E Pors; Tanni Borgbo; Erik Ernst; Kirsten T Macklon; Claus Yding Andersen
Journal:  Front Endocrinol (Lausanne)       Date:  2018-01-12       Impact factor: 5.555

View more
  2 in total

1.  Comparison of two ovarian stimulation protocols among women with poor response: A randomized clinical trial.

Authors:  Minoodokht Bavarsadkarimi; Sirous Omidi; Farinaz Shahmoradi; Zahra Heidar; Sahar Mirzaei
Journal:  Eur J Transl Myol       Date:  2022-07-06

2.  Effects of Adjuvant Growth Hormone Therapy on Poor Ovarian Responders in Assisted Reproductive Technology.

Authors:  Simin Zafardoust; Soheila Ansaripor; Atousa Karimi; Hossein Hosseinirad; Mina Ataei
Journal:  Maedica (Bucur)       Date:  2022-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.